CD8A and cancer: In vitro co‐culture of A375 cancer cells (HLA‐A*0201+, NY‐ESO‐1+) with NY‐ESO‐1 TCR‐CD8+T cells led to the efficient killing of A375 cells in a dose‐dependent manner (Figure 6c).